Vaccines

Discover the latest advancements shaping the future of vaccines with a curated mix of expert insights, emerging technologies, and strategic perspectives all in one place.

COATSOME® SS Series: Low-Toxicity LNPs with Biodegradable Ionizable Lipids

Developing a Cell-Based Potency Assay for DNA Cancer Vaccines

EVX-01 Cancer Vaccine: A Novel Personalised Immunotherapy for Melanoma

Orthopoxviruses - Lessons From The Mpox Outbreak & Future Vaccines?

Using Ultracentrifugation to Characterise mRNA-LNP Heterogeneities

How the Pandemic Catapulted mRNA Vaccines into an Established Platform Technology

Immune Modulatory Vaccines: A New Modality

Agilent's Solutions for RNA Vaccine Innovation

The Viral Vector Platform Cutting Costs Below $1/Dose

The Global Network Preparing for the Next Pandemic: Clinical Assays for Vaccine Development

Vaccine Designs in Hours Using EDEN and RAVEN AI Platforms

Microalgae Extracellular Vesicles for Therapeutic Delivery and Innate Immunity Modulation

Two AI Platforms for Truly Personalised Cancer Vaccines

HIP-Vax and Fixed Bed Technology: Pioneering the Path to $1 Vaccines

Catalysing Vaccine Access: Vaccine Inequality and Manufacturing in Africa

Leveraging Ontology to Develop a Cancer Vaccine Platform

SGS, Your Partner in Vaccine Excellence

Finding the Right Antigens for Vaccine Development

Streamline mRNA Synthesis with Takara Bio

Keeping up with the COVID Variants for Vaccine Efficacy

Scaling up Process Development to Address Unmet Needs in Oncology

Reshaping RNA Vaccine Production with Quality by Digital Design (QbDD)